Current evidence presents a complex picture
This is a life-threatening clinical-dermatological emergency that presents with a variety of symptoms and signs, including skin rash (especially of the exanthema type), which may be accompanied by fever, lymphadenomegaly, hepatitis, hematological (especially atypical lymphocytes and eosinophilia), renal, cardiac, pulmonary and pancreatic changes.1 The term DRESS was initially proposed by Bocquet et al., in 1996, in a review article on the drug hypersensitivity syndrome, which had been previously described under several different terms or synonymies, such as dapsone syndrome, anticonvulsant hypersensitivity syndrome, hydantoin syndrome, and allopurinol hypersensitivity syndrome, depending on the pharmacological agent involved, throughout the 20th century.2 The first case description compatible with DRESS was reported by Myers et al., in 1937
These practical details are not glamorous, but they directly impact the safety and efficacy of any research protocol
"The Human Tripeptide GHK and Tissue Remodeling." Journal of Biomaterials Science, Polymer Edition , vol
PlexusDx provides both options to match your preference and clinical needs, with treatment monitoring to track your progress
The mitochondrial protective mechanisms mediated by SGLT2i: from molecular basis to clinical implications
